Filed pursuant to Rule 424(b)(5) Registration Statement No. 333-277873
The information in this preliminary Prospectus Supplement is not complete and may be changed. We are not using this preliminary Prospectus Supplement or the accompanying Prospectus to offer to sell these securities or to solicit offers to buy these securities in any jurisdiction where the offer or sale is not permitted.
Subject to Completion, dated 19 March 2024
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of March 2024
Commission File Number: 001-38482
HUYA Inc.
Building A3, E-Park, 280 Hanxi Road
Panyu District, Guangzhou 511446
People’s Republic of China (Address of principal executive offices)
Indicate by... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the... (continue reading...)
More SEC Filings
View Older Stories-
Form 424B3 PUBLIC SERVICE CO OF
-
Form 425 Nocturne Acquisition Filed by: Nocturne Acquisition Corp
-
Form 4 Grindr Inc. For: Mar 16 Filed by: Zage George Raymond III
-
Form 8-K Nocturne Acquisition For: Mar 19
-
Form 4 Grindr Inc. For: Mar 16 Filed by: Lu James Fu Bin
-
Form 6-K VICINITY MOTOR CORP For: Mar 19
-
Form 6-K IceCure Medical Ltd. For: Mar 19
-
Form 13F-HR M3 Advisory Group, LLC For: Dec 31
-
Form SC TO-C PureTech Health plc Filed by: PureTech Health plc
-
Form 6-K JOYY Inc. For: Mar 19
-
Form 10-K LIXTE BIOTECHNOLOGY HOLD For: Dec 31
-
Form 8-K R1 RCM Inc. /DE For: Mar 18
-
Form 8-K Cocrystal Pharma, Inc. For: Mar 19
-
Form 8-K ARCH RESOURCES, INC. For: Mar 19
-
Form 6-K PureTech Health plc For: Mar 19
-
Form 8-K KULR Technology Group, For: Mar 19
-
Form 4 FTC Solar, Inc. For: Mar 18 Filed by: Chatila Ahmad R
-
Form 6-K Maris Tech Ltd. For: Mar 19
-
Form 424B5 Athene Holding Ltd.
-
Form 10-K Coya Therapeutics, Inc. For: Dec 31
-
Form D/A CoastEdge Focus Fund
-
Form 8-K COLUMBUS MCKINNON CORP For: Mar 18
-
Form 4 CEVA INC For: Mar 15 Filed by: SILVER LOUIS
-
Form 8-K Coya Therapeutics, Inc. For: Mar 19
-
Form D SoraFinance a Series of
-
Form 6-K Evaxion Biotech A/S For: Mar 19
-
Form 424B5 UNITEDHEALTH GROUP INC
-
Form D OPX2024 AI 03 a Series
-
Form 4 Chubb Ltd For: Mar 15 Filed by: Wayland Joseph F
-
Form D Nesh a Series of CGF2021
-
Form 6-K dLocal Ltd For: Mar 19
-
Form 8-K MICROSTRATEGY Inc For: Mar 19
-
Form D Tundra Angels Upwardli
-
Form 10-K Aterian, Inc. For: Dec 31
-
Form ARS S&P Global Inc. For: Dec 31
-
Form 144 PARK OHIO HOLDINGS CORP Filed by: WERT JAMES W
-
Form 8-K Crescent Energy Co For: Mar 19
-
Form DEFA14A Floor & Decor Holdings,
-
Form SC 13D/A Bally's Corp Filed by: Standard General L.P.
-
Form 8-K Tonix Pharmaceuticals For: Mar 19
-
Form 8-K Acumen Pharmaceuticals, For: Mar 19
-
Form 8-K MICROSTRATEGY Inc For: Mar 18
-
Form DEFA14A S&P Global Inc.
-
Form 8-K CERUS CORP For: Mar 19
-
Form 3 Northwest Bancshares, For: Mar 18 Filed by: Schosser Douglas M
-
Form DEFA14A FIRST UNITED CORP/MD/
-
Form DEF 14A Floor & Decor Holdings, For: May 08
-
Form DEF 14A S&P Global Inc. For: May 01
-
Form RW Thimble Point Acquisitio
-
Form 8-K ORAMED PHARMACEUTICALS For: Mar 14